British Indian Doctor Tony Dhillon has undertaken “ground-breaking” cancer trial

Dr Dhillon, a Consultant Medical Oncologist at the Royal Surrey NHS Foundation Trust, proposed the idea for the trial and has worked with Professor Tim Price in Australia for the last four years to develop the vaccine

PRAVASISAMWAD.COM

British Indian doctor Tony Dhillon is the chief investigator of a “ground-breaking” trial of a vaccine to treat early bowel cancer for patients worldwide, following a UK-Australia collaboration between scientists and doctors, reported PTI.

Dr Dhillon, a Consultant Medical Oncologist at the Royal Surrey NHS Foundation Trust, proposed the idea for the trial and has worked with Professor Tim Price in Australia for the last four years to develop the vaccine.

“This is ground-breaking. I feel as if we are on the edge of something really big here. The vaccine makes the immune system go after the cancer. It will be life-changing because it means that potentially, patients may not need to have surgery – they may just have the vaccine.”

The trial, announced recently, will be run by the Cancer Research UK Southampton Clinical Trials Unit at the University of Southampton in collaboration with Royal Surrey and Queen Elizabeth Hospital in Adelaide, Australia.

“This is the first treatment vaccine in any gastrointestinal cancer and we have high hopes that it will be very successful. We think that for a lot of patients, the cancer will have gone completely after this treatment,” said Dr Dhillon.

“This is ground-breaking. I feel as if we are on the edge of something really big here. The vaccine makes the immune system go after the cancer. It will be life-changing because it means that potentially, patients may not need to have surgery – they may just have the vaccine,” he said.

***********************************************************************

Readers

These are extraordinary times. All of us have to rely on high-impact, trustworthy journalism. And this is especially true of the Indian Diaspora. Members of the Indian community overseas cannot be fed with inaccurate news.

Pravasi Samwad is a venture that has no shareholders. It is the result of an impassioned initiative of a handful of Indian journalists spread around the world.  We have taken the small step forward with the pledge to provide news with accuracy, free from political and commercial influence. Our aim is to keep you, our readers, informed about developments at ‘home’ and across the world that affect you.

Please help us to keep our journalism independent and free.

In these difficult times, to run a news website requires finances. While every contribution, big or small, will makes a difference, we request our readers to put us in touch with advertisers worldwide. It will be a great help.

For more information: pravasisamwad00@gmail.com